Select Publications
Book Chapters
2023, 'Neuropathy and Other Neurological Problems in Chronic Kidney Disease', in Management of Chronic Kidney Disease: A Clinician’s Guide, Second Edition, pp. 417 - 427, http://dx.doi.org/10.1007/978-3-031-42045-0_28
,2014, 'Neuropathy and Other Neurological Problems in Chronic Kidney Disease', in Arici M (ed.), Management of Chronic Kidney Disease, Springer, pp. 343 - 352, http://dx.doi.org/10.1007/978-3-642-54637-2_26
,Journal articles
2024, 'Barriers and enablers to exercise in kidney transplant recipients: Systematic review of qualitative studies', Journal of Renal Care, 50, pp. 384 - 404, http://dx.doi.org/10.1111/jorc.12497
,2024, 'Digital Physical Activity and Exercise Interventions for People Living with Chronic Kidney Disease: A Systematic Review of Health Outcomes and Feasibility', Journal of Medical Systems, 48, http://dx.doi.org/10.1007/s10916-024-02081-z
,2024, 'Preferences of people with chronic kidney disease regarding digital health interventions that promote healthy lifestyle: qualitative systematic review with meta-ethnography', BMJ Open, 14, pp. e082345, http://dx.doi.org/10.1136/bmjopen-2023-082345
,2024, 'PERSPECTIVES OF PEOPLE WITH CHRONIC KIDNEY DISEASE REGARDING DIGITAL HEALTH INTERVENTIONS THAT PROMOTE A HEALTHY LIFESTYLE: QUALITATIVE SYSTEMATIC REVIEW', Journal of Clinical Exercise Physiology, 13, pp. 426 - 426, http://dx.doi.org/10.31189/2165-7629-13-s2.426
,2024, 'PHYSICAL ACTIVITY RECOMMENDATIONS FOR PEOPLE WITH CHRONIC KIDNEY DISEASE: ARE RESEARCH PARTICIPANTS REPRESENTATIVE OF REAL-WORLD PATIENTS?', Journal of Clinical Exercise Physiology, 13, pp. 424 - 424, http://dx.doi.org/10.31189/2165-7629-13-s2.424
,2022, 'Adolescent exposure to a solid high-fat, high-sugar ‘cafeteria’ diet leads to more pronounced changes in metabolic measures and gut microbiome composition than liquid sugar in female rats', Appetite, 172, http://dx.doi.org/10.1016/j.appet.2022.105973
,2022, 'Current and Emerging Pharmacotherapeutic Interventions for the Treatment of Peripheral Nerve Disorders', Pharmaceuticals, 15, pp. 607, http://dx.doi.org/10.3390/ph15050607
,2022, 'Peripheral nerve morphology and intraneural blood flow in chronic kidney disease with and without diabetes', Muscle and Nerve, 65, pp. 603 - 607, http://dx.doi.org/10.1002/mus.27513
,2022, 'Peripheral neuropathy: An important contributor to physical limitation and morbidity in stages 3 and 4 chronic kidney disease', Nephrology Dialysis Transplantation, 37, pp. 713 - 719, http://dx.doi.org/10.1093/ndt/gfab043
,2022, 'Peripheral Neuropathy Phenotyping in Rat Models of Type 2 Diabetes Mellitus: Evaluating Uptake of the Neurodiab Guidelines and Identifying Future Directions', Diabetes and Metabolism Journal, 46, pp. 198 - 221, http://dx.doi.org/10.4093/dmj.2021.0347
,2021, 'Effect of exenatide on peripheral nerve excitability in type 2 diabetes', Clinical Neurophysiology, 132, pp. 2532 - 2539, http://dx.doi.org/10.1016/j.clinph.2021.05.033
,2021, 'Effect of hemodiafiltration on the progression of neuropathy with kidney failure: A randomized controlled trial', Clinical Journal of the American Society of Nephrology, 16, pp. 1365 - 1375, http://dx.doi.org/10.2215/CJN.17151120
,2021, 'Impact of the metabolic syndrome on peripheral nerve structure and function in type 2 diabetes', European Journal of Neurology, 28, pp. 2074 - 2082, http://dx.doi.org/10.1111/ene.14805
,2020, 'Associations between acute glucose control and peripheral nerve structure and function in type 1 diabetes', Diabetic Medicine, 37, pp. 1553 - 1560, http://dx.doi.org/10.1111/dme.14306
,2020, 'Evidence of altered peripheral nerve function in a rodent model of diet-induced prediabetes', Biomedicines, 8, pp. 313, http://dx.doi.org/10.3390/biomedicines8090313
,2020, 'Altered peripheral nerve structure and function in latent autoimmune diabetes in adults', Diabetes/Metabolism Research and Reviews, 36, http://dx.doi.org/10.1002/dmrr.3260
,2019, 'Relative contributions of diabetes and chronic kidney disease to neuropathy development in diabetic nephropathy patients', Clinical Neurophysiology, 130, pp. 2088 - 2095, http://dx.doi.org/10.1016/j.clinph.2019.08.005
,2019, 'Polymer brush based fluorescent immunosensor for direct monitoring of interleukin-1β in rat blood', Analyst, 144, pp. 5682 - 5690, http://dx.doi.org/10.1039/c9an01300h
,2019, 'Potassium control in chronic kidney disease: implications for neuromuscular function', Internal Medicine Journal, 49, pp. 817 - 825, http://dx.doi.org/10.1111/imj.14114
,2018, 'The utility of the Total Neuropathy Score as an instrument to assess neuropathy severity in chronic kidney disease: A validation study', Clinical Neurophysiology, 129, pp. 889 - 894, http://dx.doi.org/10.1016/j.clinph.2018.02.120
,2018, '<em>In Vivo </em>Electrophysiological Measurement of the Rat Ulnar Nerve with Axonal Excitability Testing', Journal of Visualized Experiments, http://dx.doi.org/10.3791/56102-v
,2018, 'In vivo electrophysiological measurement of the rat ulnar nerve with axonal excitability testing', Journal of Visualized Experiments, 2018, http://dx.doi.org/10.3791/56102
,2018, 'Effects of hemodialysis on intraneural blood flow in end-stage kidney disease', Muscle and Nerve, 57, pp. 287 - 293, http://dx.doi.org/10.1002/mus.25704
,2017, 'Randomized, controlled trial of the effect of dietary potassium restriction on nerve function in CKD', Clinical Journal of the American Society of Nephrology, 12, pp. 1569 - 1577, http://dx.doi.org/10.2215/CJN.00670117
,2017, 'The effect of diabetes on cortical function in stroke: Implications for poststroke plasticity', Diabetes, 66, pp. 1661 - 1670, http://dx.doi.org/10.2337/db16-0961
,2017, 'Haemodialysis alters peripheral nerve morphology in end-stage kidney disease', Clinical Neurophysiology, 128, pp. 281 - 286, http://dx.doi.org/10.1016/j.clinph.2016.09.010
,2017, 'Nerve excitability in the rat forelimb: a technique to improve translational utility', Journal of Neuroscience Methods, 275, pp. 19 - 24, http://dx.doi.org/10.1016/j.jneumeth.2016.10.013
,2016, 'Association between glycemic variability and peripheral nerve dysfunction in type 1 diabetes', Muscle and Nerve, 54, pp. 967 - 969, http://dx.doi.org/10.1002/mus.25274
,2016, 'Comparative study to evaluate the effects of peritoneal and hemodialysis on peripheral nerve function', Muscle and Nerve, 54, pp. 58 - 64, http://dx.doi.org/10.1002/mus.25016
,2016, 'In vivo evidence of reduced nodal and paranodal conductances in type 1 diabetes', Clinical Neurophysiology, 127, pp. 1700 - 1706, http://dx.doi.org/10.1016/j.clinph.2015.11.047
,2016, 'Neurological complications in chronic kidney disease', JRSM Cardiovascular Disease, 5, pp. 2048004016677687 - 2048004016677687, http://dx.doi.org/10.1177/2048004016677687
,2015, 'Ion channel modulation as a therapeutic approach in multiple sclerosis', Current Medicinal Chemistry, 22, pp. 4366 - 4378, http://dx.doi.org/10.2174/0929867322666151029104452
,2015, 'Continuous subcutaneous insulin infusion preserves axonal function in type 1 diabetes mellitus', Diabetes/Metabolism Research and Reviews, 31, pp. 175 - 182, http://dx.doi.org/10.1002/dmrr.2583
,2014, 'Evidence for a causal relationship between hyperkalaemia and axonal dysfunction in end-stage kidney disease', Clinical Neurophysiology, 125, pp. 179 - 185, http://dx.doi.org/10.1016/j.clinph.2013.06.022
,2013, 'Mechanisms of axonal dysfunction in diabetic and uraemic neuropathies', Clinical Neurophysiology, 124, pp. 2079 - 2090, http://dx.doi.org/10.1016/j.clinph.2013.04.012
,2013, 'Association between calcineurin inhibitor treatment and peripheral nerve dysfunction in renal transplant recipients', American Journal of Transplantation, 13, pp. 2426 - 2432, http://dx.doi.org/10.1111/ajt.12324
,2013, 'Axonal dysfunction prior to neuropathy onset in type 1 diabetes', Diabetes - Metabolism Research and Reviews, 29, pp. 53 - 59, http://dx.doi.org/10.1002/dmrr.2360
,2013, 'Effects of Axonal Ion-Channel Dysfunction on Quality of Life in Type 2 Diabetes.', Diabetes Care, 36, pp. 1272 - 1277, http://dx.doi.org/10.2337/dc12-1310
,2013, 'Effects of Hemodiafiltration and High Flux Hemodialysis on Nerve Excitability in End-Stage Kidney Disease', PLoS ONE, 8, pp. Article number e59055, http://dx.doi.org/10.1371/journal.pone.0059055
,2012, '20. Effects of altered axonal biophysical properties on quality of life in diabetic peripheral neuropathy', Clinical Neurophysiology, 123, pp. e75 - e75, http://dx.doi.org/10.1016/j.clinph.2011.11.029
,2012, 'Progressive axonal dysfunction precedes development of neuropathy in type 2 Diabetes.', Diabetes, 61, pp. 1592 - 1598, http://dx.doi.org/10.2337/db11-1509
,2011, 'Valididty and reliability of the swaymeter device for measuring postural sway', BMC Geriatrics, 11, pp. 63, http://dx.doi.org/10.1186/1471-2318-11-63
,2010, 'DIFFERENTIAL EFFECTS OF HAEMODIAFILTRATION ON HIGH FLUX HAEMODIALYSIS ON NERVE FUNCTION IN VITRO', NEPHROLOGY, 15, pp. 86 - 86, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000208652700227&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,Conference Papers
2016, 'An axonal membrane excitability gradient could contribute to the length-dependent susceptibility to neuropathy', in EUROPEAN JOURNAL OF NEUROLOGY, WILEY, pp. 878 - 878, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000431634203497&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Effects of neuropathy on physical function and quality of life in moderate severity chronic kidney disease', in Clinical Neurophysiology, Gold Coast, Queensland, pp. e4 - e4, presented at ANZAN Clinical Neurophysiology Workshop, Gold Coast, Queensland, 29 September 2013 - 02 October 2013, http://dx.doi.org/10.1016/j.clinph.2013.10.031
,2013, 'Insulin pump therapy in type 1 diabetes: Potential to be neuroprotective', in Clinical Neurophysiology, Gold Coast, Queensland, pp. e1 - e2, presented at ANZAN Clinical Neurophysiology Workshop, Gold Coast, Queensland, 29 September 2013 - 02 October 2013, http://dx.doi.org/10.1016/j.clinph.2013.10.024
,2012, 'Effects of calcineurin inhibitor treatment on peripheral nerve function in renal transplant recipients', in American Journal of Transplantation, Boston, United States of America, pp. 116 - 116, presented at American Transplant Congress, Boston, United States of America, 02 June 2012 - 06 June 2012, http://dx.doi.org/10.1111/j.1600-6143.2012.04112.x
,2012, 'Evidence for a causal relationship between nerve dysfunction and hyperkalaemia in end-stage kidney disease', in Nephrology Dialysis Transplantation, Paris, France, pp. ii70 - ii72, presented at 49th Congress of the European Renal Association/European Dialysis and Transplant Association, Paris, France, 25 May 2012 - 27 May 2012, http://dx.doi.org/10.1093/ndt/gfs211
,